Published in Clin Exp Immunol on October 01, 1968
Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host. Clin Exp Immunol (1968) 0.86
The effect of anti-lymphocytic IgG on unsensitized and sensitized spleen cells in vivo and in vitro. Clin Exp Immunol (1969) 0.78
Graft versus host reactions. Their natural history, and applicability as tools of research. Prog Allergy (1962) 7.11
Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59
EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Nature (1963) 3.65
A MODIFIED TECHNIQUE FOR COLLECTING MOUSE THORACIC DUCT LYMPH. Nature (1965) 3.25
The use of immunologically competent cells in the treatment of cancer: experiments with a transplantable mouse tumour. Br J Cancer (1962) 3.10
Further experiments on the action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1967) 2.31
Activity of lymphoid tissues from antilymphocyte-serum-treated mice. Lancet (1967) 1.66
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Site of action of antilymphocyte globulin. Lancet (1967) 1.51
Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats. Lancet (1967) 1.41
An immunosupressive site of action of heterologous antilymphocyte serum. Lancet (1967) 1.17
In vivo and in vitro effect of anti-lymphocytic IgG on sensitized spleen cells. Nature (1968) 0.86
Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host. Clin Exp Immunol (1968) 0.86
Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. Br J Cancer (1966) 4.85
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34
Pathways in the development of liver macrophages: alternative precursors contained in populations of lymphocytes and bone-marrow cells. Proc R Soc Lond B Biol Sci (1968) 3.00
Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med (1968) 2.70
Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer (1980) 2.21
Subtotal parathyroidectomy in chronic renal failure: a seven-year experience in a dialysis and transplant program. Ann Surg (1971) 1.83
Preoperative laparoscopy in diagnosis of acute abdominal pain. Lancet (1975) 1.78
Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med (1973) 1.74
Activity of lymphoid tissues from antilymphocyte-serum-treated mice. Lancet (1967) 1.66
Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol (1995) 1.56
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet (1984) 1.54
Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci U S A (2007) 1.48
Complete nucleotide sequence of the Escherichia coli ptr gene encoding protease III. Nucleic Acids Res (1986) 1.30
Molecular aspects of the metastatic cascade. Biochim Biophys Acta (1989) 1.28
Complete nucleotide sequence of the Escherichia coli recC gene and of the thyA-recC intergenic region. Nucleic Acids Res (1986) 1.28
Analysis of recurrence patterns following curative resection for carcinoma of the colon and rectum. Surg Gynecol Obstet (1981) 1.27
Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol (1997) 1.22
Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol (1983) 1.21
The management of pathologic fractures in patients with metastatic carcinoma of the breast. Surg Gynecol Obstet (1968) 1.17
Patterns of failure after surgical cure of large liver tumors. A change in the proximate cause of death and a need for effective systemic adjuvant therapy. Am J Surg (1984) 1.14
Optimization of calcium phosphate transfection for bovine chromaffin cells: relationship to calcium phosphate precipitate formation. Anal Biochem (1995) 1.14
Disappearance of "uremic" itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.13
Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab (1982) 1.13
The effect of adult exposure to diethylstilbestrol in the mouse on macrophage function and numbers. J Reticuloendothel Soc (1980) 1.12
Familial male breast cancer. Lancet (1976) 1.10
A primate model of hyperacute renal allograft rejection. Am J Pathol (1975) 1.09
The effects of perinatal/juvenile methoxychlor exposure on adult rat nervous, immune, and reproductive system function. Fundam Appl Toxicol (1997) 1.09
In pursuit of the unknown primary. Am J Surg (1978) 1.09
Listeroisis in immunosuppressed patients. A cluster of eight cases. Am J Med (1975) 1.08
Major colonic diseases complicating renal transplantation. Surgery (1973) 1.04
Malposition of a subclavian line. Resultant pleural effusions, interstitial pulmonary edema, and chest wall abscess during total parenteral nutrition. JAMA (1975) 1.04
Lymphoid abnormalities in rats with adjuvant-induced arthritis. I. Mitogen responsiveness and lymphokine synthesis. Ann Rheum Dis (1984) 1.03
The carrier effect in the secondary response to hapten-protein conjugates. 3. The anatomical distribution of helper cells and antibody-forming-cell-precursors. Eur J Immunol (1971) 1.03
Malignant intestinal obstruction. Surgery (1980) 1.01
Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma. Combined results of two randomized trials. Arch Surg (1986) 1.01
Hemorrhagic pancreatitis. A fatal complication of renal transplantation. N Engl J Med (1966) 1.00
Immunological tolerance and inhibition by hapten. Antibiot Chemother (1969) 1.00
Prolonged cancine renal allograft survival after pretreatment with solubilized antigen. Transplantation (1969) 1.00
Treatment of chronic renal failure by transplantation and dialysis: two decades of cooperation. Ann Surg (1975) 1.00
The use and limitations of serial plasma carcinoembryonic antigen (CEA) levels as a monitor of changing metastatic liver tumor volume in patients receiving chemotherapy. Cancer (1980) 1.00
Peritoneal and alveolar macrophages derived from lymphocyte populations during graft-versus-host reaction. Br J Exp Pathol (1969) 0.99
Ibuprofen causes reduced toxic effects of interleukin 2 administration in patients with metastatic cancer. Arch Surg (1989) 0.98
Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments. Surgery (1974) 0.98
Evaluation of palliative procedures for pancreatic cancer. Am J Surg (1981) 0.98
Urological complications of renal transplantation. Br J Urol (1970) 0.97
Adoptive immunotherapy of human cancer using low-dose recombinant interleukin 2 and lymphokine-activated killer cells. Cancer Res (1988) 0.95
Abnormal calcium-regulated PTH release in normal parathyroid tissue from patients with adenoma. Am J Med (1981) 0.95
Colon and rectal carcinoma in the west of Scotland. Symptoms, histologic characteristics, and outcome. Am J Surg (1984) 0.95
Renal transplantation: a twenty-five year experience. Ann Surg (1976) 0.95
Colorectal carcinoma in patients under age 40. Ann Surg (1985) 0.95
Parallel evolution in the major haemoglobin genes of eight species of Andean waterfowl. Mol Ecol (2009) 0.94
Severe pneumonia in renal transplant patients. One year's experience. Ann Intern Med (1971) 0.94
Radioisotope renography and radioscintillation scanning in the diagnosis of homograft rejection. Surg Gynecol Obstet (1966) 0.93
Arteriovenous bypass. An effective aid to patient care. Am J Surg (1968) 0.92
Calcium metabolism and osteodystrophy after renal transplantation. Arch Intern Med (1969) 0.91
Aseptic necrosis in the femur after renal transplantation. Ann Surg (1972) 0.91
A twenty year survey of arterial complications of renal transplantation. Surg Gynecol Obstet (1975) 0.91
Sexual selection. Are ducks impressed by drakes' display? Nature (2001) 0.90
Controlled clinical trial of antilymphocyte globulin in human renal allografts. Transplant Proc (1971) 0.90
Factors responsible for urinary fistula in the renal transplant recipient. Ann Surg (1973) 0.90
Treatment of metastatic breast cancer with a combination of adrenalectomy and 5-fluorouracil. Progress report. Cancer (1971) 0.90
A study of technetium-labelled sulphide colloid uptake by regional lymph nodes draining a tumour-bearing area. Br J Surg (1978) 0.89
External parathyroid scanning with Se75 selenomethionine. Ann Surg (1965) 0.89
Identification and characterization of stripe rust resistance gene Yr34 in common wheat. Theor Appl Genet (2006) 0.89
Evaluation of adrenalectomy and hypophysectomy in the treatment of metastatic cancer of the breast. Cancer (1969) 0.88
Cytotoxic antibody after antigen pretreatment: enhancement of renal allografts. Surg Forum (1969) 0.88
Secondary hyperparathyroidism in human kidney transplant recipients. Nephron (1976) 0.88
Enhancement of rat renal allografts with F(ab')2 fragment of donor-specific antikidney serum. Surgery (1971) 0.88
Inhalation toxicity studies of the alpha,beta-unsaturated ketones: ethyl vinyl ketone. Inhal Toxicol (2001) 0.87
The effect of adjuvant immunotherapy on tumor recurrence after segmental resection of carcinogen-induced Wistar/Furth primary bowel adenocarcinomas. J Immunol (1982) 0.87
Splenectomy for lymphosarcoma. Surg Gynecol Obstet (1970) 0.86
Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth. Cancer Res (1991) 0.86
Evaluation of long-functioning human kidney transplants. Surg Gynecol Obstet (1967) 0.86
Carcinoma of the breast. A decade of new results with old concepts. N Engl J Med (1967) 0.86
Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host. Clin Exp Immunol (1968) 0.86
Dose response of 1,2-dimethylhydrazine and methylazoxymethanol acetate in the F 344 rat. Cancer Lett (1980) 0.86
Fate of tumors transplanted with a renal allograft. Transplant Proc (1975) 0.86
A twenty-five year experience with soft tissue sarcomas. Am J Surg (1970) 0.85
Circulating immune complexes in patients following clinically curative resection of colorectal cancer. Surgery (1978) 0.85
Peritoneal macrophage alterations caused by naturally occurring mouse hepatitis virus. Am J Pathol (1982) 0.85
Effect of antilymphocyte serum on macrophage activity. Clin Exp Immunol (1970) 0.85
Transplantation in patients with unusual causes of renal failure. Clin Nephrol (1976) 0.85
Preoperative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet (1978) 0.84
A new regimen of interleukin 2 and lymphokine-activated killer cells. Efficacy without significant toxicity. Arch Intern Med (1988) 0.84
Evaluation of corticosteroid therapy for acute renal allograft rejection. Surg Gynecol Obstet (1974) 0.84
Local recurrence and the deep resection margin in carcinoma of the breast. Surg Gynecol Obstet (1986) 0.84
Canine limb homotransplantation. Plast Reconstr Surg (1966) 0.84
Surgical considerations in gastric cancer. Semin Oncol (1985) 0.84
The effect of subtotal parathyroidectomy and renal transplantation on mineral balance and secondary hyperparathyroidism in chronic renal failure. Metabolism (1971) 0.84
Dog renal homografts prolonged by antigenic pretreatment. Surg Forum (1965) 0.83
Adrenalectomy with chemotherapy in the treatment of advanced breast cancer: objective and subjective response rates; duration and quality of life. Surgery (1974) 0.83
Effect of timing of lymphokine presentation on generation of cytotoxic T lymphocytes. Arch Surg (1989) 0.83
Stimulation or suppression of metastases with graded doses of tumor cells. Cancer Res (1971) 0.83
Effect of major small bowel resection on dimethylhydrazine-induced bowel carcinogenesis. J Surg Oncol (1981) 0.83
The effects of orthophenylphenol, tris(2,3-dichloropropyl) phosphate, and cyclophosphamide on the immune system and host susceptibility of mice following subchronic exposure. Toxicol Appl Pharmacol (1981) 0.83
Cadaveric kidney transplantation in a patient with donor-specific antileukocyte cytotoxic antibodies. Report of a case. Transplantation (1971) 0.83
Carcinoma of the breast. A decade of new results with old concepts. N Engl J Med (1967) 0.83